HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support.
about
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyRemote optical switch for localized and selective control of gene interference.Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit.Prognostic factors for survival in metastatic breast cancer by hormone receptor status.
P2860
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
HER2 overexpression as a progn ...... autologous stem cell support.
@en
HER2 overexpression as a progn ...... autologous stem cell support.
@nl
type
label
HER2 overexpression as a progn ...... autologous stem cell support.
@en
HER2 overexpression as a progn ...... autologous stem cell support.
@nl
prefLabel
HER2 overexpression as a progn ...... autologous stem cell support.
@en
HER2 overexpression as a progn ...... autologous stem cell support.
@nl
P2093
P2860
P356
P1476
HER2 overexpression as a progn ...... autologous stem cell support.
@en
P2093
C Orlandini
P Collecchi
V Guarneri
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704619
P407
P577
2004-09-01T00:00:00Z